Directory
>
Sean Nolan
Sean Nolan
Chief Executive Officer | Taysha Gene Therapies
Chicago, Illinois, United States
Sean Nolan
Summary
Sean P. Nolan is an accomplished leader in the biopharmaceutical industry, currently serving as the Chairman and CEO of Taysha Gene Therapies, where he focuses on developing innovative gene therapies for rare CNS diseases. With a robust history of leadership roles, including his previous position as President and CEO of AveXis, he played a pivotal role in the development of the groundbreaking gene therapy Zolgensma. His extensive experience spans various companies and positions, showcasing his expertise in business strategy, clinical trials, and commercialization. Sean's commitment to advancing healthcare is evident through his involvement on multiple boards, including Affinia Therapeutics and Encoded Therapeutics. He holds a B.A. in Biology from John Carroll University, reflecting his strong academic foundation in life sciences. Beyond his professional achievements, Sean is a dedicated family man, raising four children with his wife, Beth. His career is marked by a dedication to improving patient outcomes and driving innovation in the pharmaceutical sector.
Sean Nolan
Work Experience
Chief Executive Officer at
Taysha Gene Therapies
December 2022 - Present
Chairman of the Board of Directors at
Taysha Gene Therapies
March 2020 - Present
President and Chief Executive Officer at
AVEXIS, s.r.o.
June 2015 - May 2018
Chief Business Officer at
INTERMUNE TRUST
February 2013 - June 2015
Chief Commercial Officer at
Reata Pharmaceuticals Global, Inc.
August 2011 - December 2012
President of Lundbeck Inc. (US Affiliate of Lundbeck, Formerly Ovation Pharmaceuticals) at
Lundbeck
December 2009 - November 2010
Chief Commercial Officer/Integration Leader at
Lundbeck
March 2009 - December 2009
VP, Product Development and Global Project Management at
Lundbeck
February 2008 - March 2009
VP, CNS Business Unit at
Lundbeck
January 2006 - February 2008
VP, Marketing and Sales Operations at
Lundbeck
September 2004 - December 2005
Senior Director, Sales Operations at
Solvay Pharma Inc
July 2003 - September 2004
Director of Sales, Anti-Infectives at
Solvay Pharma Inc
July 2001 - July 2003
Director of Sales, Neuroscience at
Solvay Pharma Inc
December 1999 - July 2001
Regional Manager, Long Term Care at
Solvay Pharma Inc
July 1999 - December 1999
Senior Product Manager, Neuroscience at
Solvay Pharma Inc
May 1996 - January 1999
District Sales Manager, Neuroscience at
Solvay Pharma Inc
January 1996 - May 1997
Associate Marketing Manager, Cardiovascular at
Solvay Pharma Inc
January 1995 - January 1996
Sales Training Manager, Anti-Infectives at
Solvay Pharma Inc
September 1993 - December 1994
Sales Representative, Anti-Infectives at
Solvay Pharma Inc
May 1991 - September 1993
Sean Nolan
Education
John Carroll University, B.S.
January 1986 - January 1990
Frequently Asked Questions about Sean Nolan
What is Sean Nolan email address?
Sean Nolan's primary email address is ******@tayshagtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Sean Nolan work for?
Sean Nolan is a Chief Executive Officer at Taysha Gene Therapies, a company specializing in Offices of health practitioner.
Where Sean Nolan graduated from?
Sean Nolan holds a degree in Biology from John Carroll University.
How can I directly contact Sean Nolan?
To contact Sean Nolan directly, you can use the email address ******@tayshagtx.com. Complete contact information is available upon registration with Muraena.
Who is Sean Nolan?
Sean P. Nolan is an accomplished leader in the biopharmaceutical industry, currently serving as the Chairman and CEO of Taysha Gene Therapies, where he focuses on developing innovative gene therapies for rare CNS diseases. With a robust history of leadership roles, including his previous position as President and CEO of AveXis, he played a pivotal role in the development of the groundbreaking gene therapy Zolgensma. His extensive experience spans various companies and positions, showcasing his expertise in business strategy, clinical trials, and commercialization. Sean's commitment to advancing healthcare is evident through his involvement on multiple boards, including Affinia Therapeutics and Encoded Therapeutics. He holds a B.A. in Biology from John Carroll University, reflecting his strong academic foundation in life sciences. Beyond his professional achievements, Sean is a dedicated family man, raising four children with his wife, Beth. His career is marked by a dedication to improving patient outcomes and driving innovation in the pharmaceutical sector.
Sean`s contact details
******@tayshagtx.com
**********@att.net
******@stiefel.com
******@avexis.com
Colleagues
Director, Business Development & R&D Chief of Staff
Chief Technical Officer
President
Medical Affairs
Executive Director, Quality
Chief Financial Officer
Executive Director, Head of Patient Advocacy
Head of Market Access and Trade
Chief Patient and External Affairs Officer
Chief Patient Officer and Head of Government Affairs